Fierce Pharma
MARCH 25, 2024
In 2023, Eli Lilly CEO David Ricks received a 24% boost in pay from $21.4 million to $26.6 million. The increase coincides with the company's booming sales.
MedCity News
MARCH 25, 2024
AbbVie is acquiring Landos Biopharma, whose lead drug is a small molecule that takes a novel approach to treating ulcerative colitis. Preliminary proof-of-concept data from a Phase 2 study are expected later this year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MARCH 25, 2024
Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. | Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. officials are pressing the company to pay royalties linked to the commercialization of its lucrative Pfizer-partnered COVID-19 vaccine.
MedCity News
MARCH 25, 2024
Novo Nordisk’s strategy to grow beyond metabolic diseases includes expanding into adjacent areas such as cardiovascular disease. Acquiring Cardio Pharmaceuticals adds a novel RNA-based therapy that is a potential heart failure treatment.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
MARCH 25, 2024
With the FDA expected this week to approve a first-in-class treatment from Merck for pulmonary arterial hypertension (PAH), Johnson & Johnson has beaten its New Jersey rival to the punch with a | With the FDA expected this week to approve a first-in-class treatment from Merck for pulmonary arterial hypertension (PAH), Johnson & Johnson has beaten its New Jersey rival to the punch with a nod from the U.S. regulator for its newest PAH treatment.
pharmaphorum
MARCH 25, 2024
Novo Nordisk has agreed to buy Cardior Pharmaceuticals for $1.1 billion, adding expertise in RNA therapeutics and a heart failure therapy in mid-stage trials.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MARCH 25, 2024
David Kereiakes, managing partner with Windham Venture Partners, shared his perspective of the health tech sector and investment trends he’s seeing.
Fierce Pharma
MARCH 25, 2024
The four years since the start of the COVID-19 pandemic have yielded many advances against the coronavirus, including Moderna and Pfizer’s groundbreaking mRNA vaccines. | The agency granted emergency use authorization to Invivyd's Pemgarda, a monoclonal antibody for those who are immunocompromised and unlikely to receive adequate protection from marketed mRNA vaccines.
MedCity News
MARCH 25, 2024
During an interview this month at HIMSS24, David Vawdrey — Geisinger’s chief data and informatics officer said health systems should spend more time designing their plan for evaluating success when it comes to tech pilots.
Fierce Pharma
MARCH 25, 2024
When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC) isn’t backing down. | After filing a challenge in November against more than 100 patents in the FDA’s Orange Book—and persuading several drugmakers to retract their intellectual property (IP) protections in the process—the U.S. Federal Trade Commission is now calling out uncooperative companies in court.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
MARCH 25, 2024
Data strategy requires understanding all data feeds and ensuring secure, privacy-compliant data access and governance. How you use your data is the primary concern. The systems and tools are secondary.
pharmaphorum
MARCH 25, 2024
Three digital health technologies (DHTs) used to support patients with psychosis can be used by the NHS while additional evidence of their benefits is gathered.
MedCity News
MARCH 25, 2024
It’s a complex, multifaceted problem that no magic bullet will solve — but more visibility into the data behind hiring and salaries for RNs may help. Here’s a look at how.
PharmaVoice
MARCH 25, 2024
As the new weight loss drugs take the world by storm, companies in other areas are battening the hatches for when slimmer patients need fewer medical interventions.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
MARCH 25, 2024
Many women going through menopause suffer brain fog, but some may be worried about a more serious cognitive condition like dementia. Because of this, Midi Health and Neurotrack partnered to offer a cognitive assessment to patients.
pharmaphorum
MARCH 25, 2024
FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma
Pharmaceutical Technology
MARCH 25, 2024
Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.
pharmaphorum
MARCH 25, 2024
The March meeting of the EMA’s human medicines committee saw an approval recommendation for Novartis’ Fabhalta, on track to become the first oral monotherapy for rare disease paroxysmal nocturnal haemoglobinuria (PNH) in the EU.
Pharmaceutical Technology
MARCH 25, 2024
The US FDA approved Johnson & Johnson's (J&J) OPSYNVI for chronic treatment in adult patients with pulmonary arterial hypertension.
PharmaVoice
MARCH 25, 2024
Deborah Reardon is leading a new pillar that asks, ‘Are we looking at this from a patient lens and not from a Boehringer lens?
Pharmaceutical Technology
MARCH 25, 2024
The FDA granted accelerated approval for the drug back in November 2022, and granted priority review in December 2023.
European Pharmaceutical Review
MARCH 25, 2024
Astellas Ireland, a wholly owned subsidiary of Astellas, has officially marked the start of construction of a new €330 million manufacturing facility at Kerry Technology Park in Tralee, Ireland. The ground-breaking ceremony, held on 25 March, was attended by Irish government officials as well as project partners and senior executives from Astellas. The new 17,000 square meter state-of-the-art facility will accelerate the expansion of Astellas’ in-house manufacturing capabilities, including for a
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTimes
MARCH 25, 2024
Estimated to affect 2.
Pharmaceutical Technology
MARCH 25, 2024
The CRISPR-based assay significantly accelerates the current diagnostic process, which can last for months and could revolutionise the way NTM infections are diagnosed.
Pharmacy Times
MARCH 25, 2024
Vitamin A regulates stem cell differentiation to manage wound healing, although risk of tumor growth may increase if differentiation does not occur.
PharmaTech
MARCH 25, 2024
In this episode of the Drug Solutions Podcast, Jan Bekkar, director of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmacy Times
MARCH 25, 2024
The indication is for adults and adolescents with moderate to severe immune compromise due to medical conditions or immunosuppressive medications and treatments.
Spotio
MARCH 25, 2024
Want to succeed in the solar industry? You need to optimize your company’s solar sales funnel. If you don’t, you won’t be able to attract qualified prospects, close deals, and drive revenue. Of course, wanting to improve your solar sales process and actually doing it are different things. To help, we’ve put together this comprehensive guide, which will help you understand the unique aspects of selling solar products, the four distinct stages of the solar sales funnel, bes
Pharmacy Times
MARCH 25, 2024
The combination tablet (Opsynvi; Johnson & Johnson) can also be used for individuals with pulmonary arterial hypertension who are being treated with stable doses of macitentan and tadalafil as separate tables.
Impetus Digital
MARCH 25, 2024
This is a guest article and does not necessarily reflect the views and values of Impetus Digital. Data breaches can happen in any industry, and unfortunately, pharmaceutical companies aren’t immune to this threat. With a handful of big names responsible for dispensing billions of prescriptions across the US each year, Pharma companies are the keepers of vast amounts of data and, as such, are attractive targets for cybercriminals.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
359 
Let's personalize your content